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CABG with different safety and efﬁcacy proﬁle. Our results should be conﬁrmed in
the ongoing randomized clinical trial.
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Background: Coronary ﬂow capacity (CFC) is a cross-modality physiological
concept, which integrates both CFR and hyperemic ﬂow to depict the ischemic burden
of the myocardium. Originally derived from positron emission tomography (PET)
imaging, moderate to severe impairment of CFC has been strongly linked to electrical
and clinical manifestations of myocardial ischemia, while no ischemia occurs with
normal or mildly reduced CFC. Analogous to PET-derived CFC, we derived an
invasive CFC concept, and studied the relationship of fractional ﬂow reserve (FFR)
and hyperemic stenosis resistance (HSR) with CFC-deﬁned blood ﬂow impairment.
Methods: Coronary pressure and ﬂow velocity were measured in 299 stenoses. After
stratiﬁcation in normal, mildly reduced, moderately reduced, and severely reduced
CFC using literature-derived CFR cut-offs and the corresponding hyperemic ﬂow
velocity percentiles, FFR and HSR outcomes were evaluated across the four CFC
groups.
Results: Identiﬁcation of severely reduced CFC was excellent for FFR0.80 (90%
agreement) and HSR>0.80 mm Hg/cm/s (92% agreement). However, 40% and 43%
of vessels with normal or mildly reduced CFC had a positive FFR (0.80). Notably,
FFR decreased to 0.77 [0.71-0.81] and 0.49 [0.40-0.64] in the moderately and severely
reduced CFC categories (P< 0.05 compared with all other CFC categories), where
75% of stenoses with severely reduced CFC had FFR< 0.65. HSR increased signif-
icantly with decreasing CFC, and showed less discordance with CFC than FFR (6%
and 11% for normal or mildly reduced CFC). Notably, 13 out of 15 stenoses asso-
ciated with moderately or severely reduced CFC not identiﬁed by FFR0.80, were
characterized by high HMR (3.24 mm Hg/cm/s [2.69 – 3.37 mm Hg/cm/s]), and low
HSR (0.53 mm Hg/cm/s [0.46 – 0.60 mm Hg/cm/s]), suggestive of microcirculatory
disease or low-ﬂow ischemia.
Conclusions: Coronary ﬂow characteristics that determine signs of ischemia are
associated with FFR values far below contemporary interventional thresholds. FFR
seems oversensitive in high-ﬂow settings, and insensitive in low-ﬂow settings. These
ﬁndings corroborate concerns using a pressure-derived estimate of coronary ﬂow
impairment.
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Background: Recently, several parameters (iFR, Pd/Pa and BSR) were proposed to
detect functional signiﬁcance of coronary artery disease (CAD) using baseline coro-
nary pressure, obviating the need for hyperemia. These parameters show a good
correlation with hyperemic fractional ﬂow reserve (FFR). Coronary autoregulation,
i.e. more dilation in case of more severe epicardial stenosiscould be an explanation.
Although some experimental data point in this direction, the hypothesis has never
been tested in humans.
Methods: Simultaneous measurements of coronary pressure and Doppler ﬂow ve-
locity were obtained in 253 vessels in patients with suspected CAD. FFR was used to
indicate functional stenosis severity, while baseline Pd/Pa determined the transstenotic
pressure ratio. Coronary resistance reserve (CRR) was deﬁned as the ratio of hyper-
emic and basal microvascular resistance, indicating the degree of autoregulation.
Baseline average peak velocity (APV) was used as surrogate for coronary ﬂow.
Results: The ﬁgure shows that with increasing stenosis severity (by FFR), baseline
Pd/Pa shows a concomitant progressive decline (P< 0.001 for trend). Also, CRR
decreases with increasing stenosis severity (P< 0.001 for trend) and a stable baseline
APV is maintained (P¼0.25 for trend).
Conclusions: With progressive stenosis severity, baseline coronary ﬂow is preserved
by microvascular resistance reduction (coronary autoregulation), resulting in
decreased perfusion pressure. This explains in part the good performance of resting
pressure measurements to detect signiﬁcant CAD.JACC Vol 64/11/Suppl B j September 13–17, 2014 j TCT Abstracts/FFTCT-323
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Background: FFR explicitly selected whole-cycle measurements to focus on
epicardial resistance while minimizing capacitive and inductive effects. However,
subsequent work proposed diastolic FFR because coronary ﬂow occurs predominately
during this phase of the cardiac cycle.
Methods: VERIFY enrolled consecutive patients from 5 global sites and used IV
adenosine hyperemia. Each FFR measurement was repeated following a 2 minute rest
period. Whole-cycle and diastolic FFR were computed at a central core lab by
averaging 5 consecutive cycles. Diastole began at the dicrotic notch and ended at the
anacrotic limb.
Results: In 206 patients, test/retest repeatability was excellent for both whole-cycle
and diastolic FFR. An extremely linear relationship existed between the two FFR
metrics, implying that whole-cycle FFR explains 95% of the variation in diastolic
FFR. ROC analysis demonstrated an AUC over 98% for diastolic FFR to predict
FFR0.8.R and Physiologic Lesion Assessment B93
